Boule Diagnostics AB (publ) (STO:BOUL)

Market Cap	205.04M
Revenue (ttm)	512.66M
Net Income (ttm)	-80.98M
Shares Out	38.83M
EPS (ttm)	-2.10
PE Ratio	n/a
Forward PE	7.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,673
Average Volume	43,733
Open	5.28
Previous Close	5.28
Day's Range	5.10 - 5.34
52-Week Range	4.60 - 10.60
Beta	0.24
RSI	47.55
Earnings Date	Feb 11, 2026

About Boule Diagnostics AB

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1956
• Employees: 200
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BOUL